Mengke Sun

Mengke Sun

Auto-generated profile, based on publicly available information

Mengke Sun

Immunology Department, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), Tianjin Medical University, Tianjin 300070, China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 March 2022 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
JHJunkai Huang
Junkai Huang
XFXiaoyue Feng
Xiaoyue Feng
JZJie Zeng
Jie Zeng
SZShuchang Zhang
Shuchang Zhang
JZJing Zhang
Jing Zhang
LHLizhi Hu
Lizhi Hu
NF-erythroid 2–related factor 2 (Nrf2) is a major transcription factor to protect cells against reactive oxygen species (ROS) and reactive toxicants. Meanwhile, Nrf2 can inhibit contact dermatitis through redox-dependent and -independent pathways. However, the underlying mechanisms of how Nrf2 mediates irritant contact dermatitis (ICD) are still unclear. In this article, we elucidated the role of Nrf2 in 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced acute ICD. Our study demonstrated that the ear thickness, redness, swelling, and neutrophil infiltration were significantly increased, accompanied by increased expression of inflammatory cytokines (IL-1α, IL-1β, IL-6, etc.) and decreased expression of antioxidant genes (HO-1 and NQO1) in Nrf2 knockout mice. Moreover, ERK phosphorylation was elevated in mouse embryonic fibroblasts (MEFs) from Nrf2 knockout mouse. Inhibition of ERK significantly alleviated TPA-induced cutaneous inflammation and ROS accumulation in MEFs derived from mouse. Conversely, ROS scavenging inhibited the ERK activation and TPA-induced inflammation in MEFs. Taken together, the findings illustrate the key role of the Nrf2/ROS/ERK signaling pathway in TPA-induced acute ICD. Key Points Nrf2 deficiency aggravates inflammatory response in ICD. Nrf2 plays a critical role in ICD through the HO-1/NQO1–ROS–ERK pathway.

1 January 2021 in BioMed Research International
Verified
Journal Article
Open access
PDF file
SWSi Wen
Si Wen
MSMengke Sun
Mengke Sun
LYLi Ye
Li Ye
BYBin Yang
Bin Yang
LHLizhi Hu
Lizhi Hu
MMMao-Qiang Man
Mao-Qiang Man
The benefits of emollients for eczematous dermatitis and psoriasis have been thought to be due to the improvements in epidermal function, including epidermal permeability barrier, stratum corneum hydration, and stratum corneum pH. We determined here whether emollient can direct inhibit cutaneous inflammation. Ear inflammation was induced by topical application of either 12‐O‐tetradecanoylphorbol‐13‐acetate (TPA) or 1‐fluoro‐2,4‐dinitrofluorobenzene (DNFB). Either 1% hydrocortisone cream or the novel emollient was applied to the right ear of the mice 45 min and 2 hours after TPA or DNFB application. The untreated left ear served as untreated controls. Both ear weight and ear thickness were measured 24 hours after TPA and DNFB application. Topical applications of either hydrocortisone cream or emollient significantly decreased both ear thickness and ear weight in comparison to untreated controls. In DNFB model, hydrocortisone significantly lowered expression levels of mRNA for IL‐1α, IL‐1β, and TNFα, while the emollient markedly decreased expression levels of IL‐1α and TNFα mRNA. In TPA model, both hydrocortisone and emollient significantly decreased expression levels of IL‐1α, IL‐1β, IL‐6, and TNFα mRNA. In parallel, inflammatory infiltration was also reduced by topical applications of either hydrocortisone or emollient. These results demonstrate that this novel emollient can directly inhibit cutaneous inflammation in murine models of both acute irritant contact dermatitis and acute allergic contact dermatitis. However, whether this emollient could also alleviate eczematous dermatitis in humans remains to be explored.

16 September 2025 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
MSMengke Sun
Mengke Sun
PGPan Guo
Pan Guo
QGQi Guo
Qi Guo
HLHui Li
Hui Li
JHJunkai Huang
Junkai Huang
LHLizhi Hu
Lizhi Hu

16 January 2026 in International Immunopharmacology
Verified
Journal Article
Closed access
JLJing Luo
Jing Luo
MLMingwei Li
Mingwei Li
DZDi Zhao
Di Zhao
HCHong Chen
Hong Chen
JHJunkai Huang
Junkai Huang
LHLizhi Hu
Lizhi Hu

9 December 2025 in Chemical Biology & Drug Design
Verified
Journal Article
Closed access
PGPan Guo
Pan Guo
MSMengke Sun
Mengke Sun
HCHong Cui
Hong Cui
JZJingyu Zhang
Jingyu Zhang
JHJunkai Huang
Junkai Huang
LHLizhi Hu
Lizhi Hu

17 July 2026 in Experimental Dermatology
Verified
Journal Article
Closed access
PDF file
WJWeiwei Jiang
Weiwei Jiang
MSMengke Sun
Mengke Sun
JHJunchen He
Junchen He
TWTianxue Wang
Tianxue Wang
TGTao Guo
Tao Guo
LHLizhi Hu
Lizhi Hu